Growth hormone response to physical exercise in growing patients with classic congenital adrenal hyperplasia

C. Bizzarri, G. Ubertini, F. Crea, D. Colabianchi, S. Loche, L. Ravà, M. Cappa

Research output: Contribution to journalArticle

Abstract

Glucocorticoid over-treatment in children with congenital adrenal hyperplasia (CAH) may suppress GH secretion and growth. Aims of our study were: 1) to evaluate post-exercise GH response in patients affected by CAH due to 21-hydroxylase deficiency, in comparison with a group of healthy subjects; 2) to investigate the relationship between the hormonal markers of adequate steroid therapy and GH secretion. We evaluated GH secretion every 6 months in 20 young CAH patients (8 girls, 12 boys). Mean follow-up was 4.6±0.9 yr (107 tests performed, 5.35±2.05 repeated tests for each patient). Forty-four healthy subjects (25 boys, 19 girls) were selected as a control group. The range of post-exercise GH peak was very wide, but medians were not statistically different in cases and controls (p=0.570). Multivariate analysis showed that post-exercise GH peak was not related to age (p=0.743), gender (p=0.296) or pubertal status (p=0.440) in both groups. GH increase from baseline showed the same behavior (p=0.265, 0.639 and 0.105, respectively). In CAH patients, GH peak and GH increase were both directly related to 17-OH-progesterone levels [GH peak: p=0.032 - 95% confidence interval (CI): 0.01-0.34 - β=0.18; GH increase: p=0.008 - 95% CI: 0.06-0.35 - ß=0.20]. The negative effect of glucocorticoid therapy on GH secretion seems to be dominant in CAH. The most effective approach to adjust treatment remains monitoring growth. Relying on hormonal markers to adequate steroid therapy may result in over-treatment, GH suppression, and finally poor linear growth.

Original languageEnglish
Pages (from-to)903-907
Number of pages5
JournalJournal of Endocrinological Investigation
Volume32
Issue number11
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Congenital Adrenal Hyperplasia
Growth Hormone
Exercise
Glucocorticoids
Healthy Volunteers
Therapeutics
Growth
Steroids
Confidence Intervals
Progesterone
Multivariate Analysis
Control Groups

Keywords

  • Child
  • Congenital adrenal hyperplasia
  • Exercise
  • GH
  • Growth

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Growth hormone response to physical exercise in growing patients with classic congenital adrenal hyperplasia. / Bizzarri, C.; Ubertini, G.; Crea, F.; Colabianchi, D.; Loche, S.; Ravà, L.; Cappa, M.

In: Journal of Endocrinological Investigation, Vol. 32, No. 11, 12.2009, p. 903-907.

Research output: Contribution to journalArticle

@article{4f7d2eb746d74469916e902d91bb8009,
title = "Growth hormone response to physical exercise in growing patients with classic congenital adrenal hyperplasia",
abstract = "Glucocorticoid over-treatment in children with congenital adrenal hyperplasia (CAH) may suppress GH secretion and growth. Aims of our study were: 1) to evaluate post-exercise GH response in patients affected by CAH due to 21-hydroxylase deficiency, in comparison with a group of healthy subjects; 2) to investigate the relationship between the hormonal markers of adequate steroid therapy and GH secretion. We evaluated GH secretion every 6 months in 20 young CAH patients (8 girls, 12 boys). Mean follow-up was 4.6±0.9 yr (107 tests performed, 5.35±2.05 repeated tests for each patient). Forty-four healthy subjects (25 boys, 19 girls) were selected as a control group. The range of post-exercise GH peak was very wide, but medians were not statistically different in cases and controls (p=0.570). Multivariate analysis showed that post-exercise GH peak was not related to age (p=0.743), gender (p=0.296) or pubertal status (p=0.440) in both groups. GH increase from baseline showed the same behavior (p=0.265, 0.639 and 0.105, respectively). In CAH patients, GH peak and GH increase were both directly related to 17-OH-progesterone levels [GH peak: p=0.032 - 95{\%} confidence interval (CI): 0.01-0.34 - β=0.18; GH increase: p=0.008 - 95{\%} CI: 0.06-0.35 - {\ss}=0.20]. The negative effect of glucocorticoid therapy on GH secretion seems to be dominant in CAH. The most effective approach to adjust treatment remains monitoring growth. Relying on hormonal markers to adequate steroid therapy may result in over-treatment, GH suppression, and finally poor linear growth.",
keywords = "Child, Congenital adrenal hyperplasia, Exercise, GH, Growth",
author = "C. Bizzarri and G. Ubertini and F. Crea and D. Colabianchi and S. Loche and L. Rav{\`a} and M. Cappa",
year = "2009",
month = "12",
doi = "10.3275/6381",
language = "English",
volume = "32",
pages = "903--907",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "11",

}

TY - JOUR

T1 - Growth hormone response to physical exercise in growing patients with classic congenital adrenal hyperplasia

AU - Bizzarri, C.

AU - Ubertini, G.

AU - Crea, F.

AU - Colabianchi, D.

AU - Loche, S.

AU - Ravà, L.

AU - Cappa, M.

PY - 2009/12

Y1 - 2009/12

N2 - Glucocorticoid over-treatment in children with congenital adrenal hyperplasia (CAH) may suppress GH secretion and growth. Aims of our study were: 1) to evaluate post-exercise GH response in patients affected by CAH due to 21-hydroxylase deficiency, in comparison with a group of healthy subjects; 2) to investigate the relationship between the hormonal markers of adequate steroid therapy and GH secretion. We evaluated GH secretion every 6 months in 20 young CAH patients (8 girls, 12 boys). Mean follow-up was 4.6±0.9 yr (107 tests performed, 5.35±2.05 repeated tests for each patient). Forty-four healthy subjects (25 boys, 19 girls) were selected as a control group. The range of post-exercise GH peak was very wide, but medians were not statistically different in cases and controls (p=0.570). Multivariate analysis showed that post-exercise GH peak was not related to age (p=0.743), gender (p=0.296) or pubertal status (p=0.440) in both groups. GH increase from baseline showed the same behavior (p=0.265, 0.639 and 0.105, respectively). In CAH patients, GH peak and GH increase were both directly related to 17-OH-progesterone levels [GH peak: p=0.032 - 95% confidence interval (CI): 0.01-0.34 - β=0.18; GH increase: p=0.008 - 95% CI: 0.06-0.35 - ß=0.20]. The negative effect of glucocorticoid therapy on GH secretion seems to be dominant in CAH. The most effective approach to adjust treatment remains monitoring growth. Relying on hormonal markers to adequate steroid therapy may result in over-treatment, GH suppression, and finally poor linear growth.

AB - Glucocorticoid over-treatment in children with congenital adrenal hyperplasia (CAH) may suppress GH secretion and growth. Aims of our study were: 1) to evaluate post-exercise GH response in patients affected by CAH due to 21-hydroxylase deficiency, in comparison with a group of healthy subjects; 2) to investigate the relationship between the hormonal markers of adequate steroid therapy and GH secretion. We evaluated GH secretion every 6 months in 20 young CAH patients (8 girls, 12 boys). Mean follow-up was 4.6±0.9 yr (107 tests performed, 5.35±2.05 repeated tests for each patient). Forty-four healthy subjects (25 boys, 19 girls) were selected as a control group. The range of post-exercise GH peak was very wide, but medians were not statistically different in cases and controls (p=0.570). Multivariate analysis showed that post-exercise GH peak was not related to age (p=0.743), gender (p=0.296) or pubertal status (p=0.440) in both groups. GH increase from baseline showed the same behavior (p=0.265, 0.639 and 0.105, respectively). In CAH patients, GH peak and GH increase were both directly related to 17-OH-progesterone levels [GH peak: p=0.032 - 95% confidence interval (CI): 0.01-0.34 - β=0.18; GH increase: p=0.008 - 95% CI: 0.06-0.35 - ß=0.20]. The negative effect of glucocorticoid therapy on GH secretion seems to be dominant in CAH. The most effective approach to adjust treatment remains monitoring growth. Relying on hormonal markers to adequate steroid therapy may result in over-treatment, GH suppression, and finally poor linear growth.

KW - Child

KW - Congenital adrenal hyperplasia

KW - Exercise

KW - GH

KW - Growth

UR - http://www.scopus.com/inward/record.url?scp=77649208902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649208902&partnerID=8YFLogxK

U2 - 10.3275/6381

DO - 10.3275/6381

M3 - Article

C2 - 19564720

AN - SCOPUS:77649208902

VL - 32

SP - 903

EP - 907

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 11

ER -